Loading clinical trials...
Loading clinical trials...
A Phase 2/3, Randomized, Observer-blind, Controlled, Multi-Center Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine (NmCV-5) and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age
Conditions
Interventions
NmCV-5
Menactra
Locations
11
India
Kempegowda Institute of Medical Sciences (KIMS) Hospital & Research Centre, K. R. Road, V. V. Puram, Bangalore 560004, Karnataka, India
Bangalore, Karnataka, India
M S Ramaiah Medical College and Hospitals, Bangalore
Bangalore, Karnataka, India
T. N. Medical College and B. Y. L. Nair Charitable
Mumbai, Maharashtra, India
Seth G S Medical College & KEM Hospital
Mumbai, Maharashtra, India
Jahangir Clinical Development Centre Pvt. Ltd., Pune
Pune, Maharashtra, India
KEM Hospital Research Centre, Vadu Rural Health Program, Vadu Budruk, Taluka - Shirur, District - Pune 412216 , Maharashtra Pune
Pune, Maharashtra, India
Start Date
December 27, 2019
Primary Completion Date
March 24, 2021
Completion Date
March 24, 2021
Last Updated
September 8, 2021
Lead Sponsor
Serum Institute of India Pvt. Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions